Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123538542 | 12353854 | 2 | F | 2010 | 20160524 | 20160511 | 20160704 | PER | US-JNJFOC-20160319991 | JANSSEN | 0.00 | A | F | Y | 61.24000 | KG | 20160704 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123538542 | 12353854 | 1 | PS | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | 3 TO 4 TIMES DAILY, STARTED IN 1990'S | N | 14KG500 | 20281 | 50 | MG | TABLETS | |||||
| 123538542 | 12353854 | 2 | SS | ULTRAM ER | TRAMADOL HYDROCHLORIDE | 1 | Oral | AT NIGHT | N | N | 14H106P | 0 | 100 | MG | SUSTAINED RELEASE TABLETS | QD | |||
| 123538542 | 12353854 | 3 | SS | ULTRAM ER | TRAMADOL HYDROCHLORIDE | 1 | Oral | AT NIGHT | N | N | 14H106P | 0 | 100 | MG | SUSTAINED RELEASE TABLETS | QD | |||
| 123538542 | 12353854 | 4 | SS | ULTRAM ER | TRAMADOL HYDROCHLORIDE | 1 | Oral | AT NIGHT | N | N | 14H106P | 21692 | 100 | MG | SUSTAINED RELEASE TABLETS | QD | |||
| 123538542 | 12353854 | 5 | SS | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | N | N | UNKNOWN | 21692 | SUSTAINED RELEASE TABLETS | ||||||||
| 123538542 | 12353854 | 6 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | CAPSULE | BID | |||||||
| 123538542 | 12353854 | 7 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 0 | 1 | DF | POWDER | QD | |||||||
| 123538542 | 12353854 | 8 | C | S-ADENOSYLMETHIONINE SULFATE P-TOLUENESULFONATE | ADEMETIONINE SULFATE TOSILATE | 1 | Oral | 0 | 200 | MG | TABLET | BID | |||||||
| 123538542 | 12353854 | 9 | C | RESVERATROL | RESVERATROL | 1 | Oral | 0 | 100 | MG | CAPSULE | QD | |||||||
| 123538542 | 12353854 | 10 | C | RESVERATROL | RESVERATROL | 1 | Oral | 0 | 100 | MG | CAPSULE | QD | |||||||
| 123538542 | 12353854 | 11 | C | ZINC | ZINCINC CHLORIDE | 1 | Oral | 0 | 20 | MG | TABLET | ||||||||
| 123538542 | 12353854 | 12 | C | GLUCOSAMINE/MSM | 2 | Oral | 0 | CAPSULE | |||||||||||
| 123538542 | 12353854 | 13 | C | TURMERIC | TURMERIC | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 14 | C | COQ 10 | UBIDECARENONE | 1 | Oral | 0 | 100 | MG | TABLET | ||||||||
| 123538542 | 12353854 | 15 | C | COQ 10 | UBIDECARENONE | 1 | Oral | 0 | 100 | MG | TABLET | ||||||||
| 123538542 | 12353854 | 16 | C | CALCIUM + VIT D | CALCIUMVITAMIN D | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 17 | C | CALCIUM + VIT D | CALCIUMVITAMIN D | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 18 | C | CALCIUM + VIT D | CALCIUMVITAMIN D | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 19 | C | VITAMIN K | PHYTONADIONE | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 20 | C | VITAMIN K | PHYTONADIONE | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 21 | C | VITAMIN K | PHYTONADIONE | 1 | Oral | 0 | TABLET | ||||||||||
| 123538542 | 12353854 | 22 | C | CHONDROITIN | CHONDROITIN | 1 | Oral | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123538542 | 12353854 | 1 | Pain |
| 123538542 | 12353854 | 2 | Pain |
| 123538542 | 12353854 | 3 | Pain |
| 123538542 | 12353854 | 4 | Pain |
| 123538542 | 12353854 | 5 | Pain |
| 123538542 | 12353854 | 6 | Oesophagitis |
| 123538542 | 12353854 | 7 | Constipation |
| 123538542 | 12353854 | 8 | Fibromyalgia |
| 123538542 | 12353854 | 9 | Prophylaxis |
| 123538542 | 12353854 | 10 | Cardiovascular disorder |
| 123538542 | 12353854 | 11 | Immune system disorder |
| 123538542 | 12353854 | 12 | Arthropathy |
| 123538542 | 12353854 | 13 | Arthropathy |
| 123538542 | 12353854 | 14 | Cardiovascular disorder |
| 123538542 | 12353854 | 15 | Fibromyalgia |
| 123538542 | 12353854 | 16 | Muscle disorder |
| 123538542 | 12353854 | 17 | Arthropathy |
| 123538542 | 12353854 | 18 | Bone disorder |
| 123538542 | 12353854 | 19 | Muscle disorder |
| 123538542 | 12353854 | 20 | Arthropathy |
| 123538542 | 12353854 | 21 | Bone disorder |
| 123538542 | 12353854 | 22 | Arthropathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123538542 | 12353854 | Activities of daily living impaired | |
| 123538542 | 12353854 | Breakthrough pain | |
| 123538542 | 12353854 | Fatigue | |
| 123538542 | 12353854 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123538542 | 12353854 | 3 | 2010 | 0 | ||
| 123538542 | 12353854 | 4 | 201603 | 0 | ||
| 123538542 | 12353854 | 7 | 2000 | 0 | ||
| 123538542 | 12353854 | 8 | 1994 | 0 | ||
| 123538542 | 12353854 | 9 | 2016 | 0 | ||
| 123538542 | 12353854 | 10 | 2016 | 0 | ||
| 123538542 | 12353854 | 11 | 2004 | 0 | ||
| 123538542 | 12353854 | 12 | 2004 | 0 | ||
| 123538542 | 12353854 | 13 | 2004 | 0 | ||
| 123538542 | 12353854 | 14 | 2000 | 0 | ||
| 123538542 | 12353854 | 15 | 2000 | 0 | ||
| 123538542 | 12353854 | 16 | 1995 | 0 | ||
| 123538542 | 12353854 | 17 | 1995 | 0 | ||
| 123538542 | 12353854 | 18 | 1995 | 0 | ||
| 123538542 | 12353854 | 19 | 1995 | 0 | ||
| 123538542 | 12353854 | 20 | 1995 | 0 | ||
| 123538542 | 12353854 | 21 | 1995 | 0 | ||
| 123538542 | 12353854 | 22 | 2004 | 0 |